Utah Department of Health calls for a âpauseâ in use of the Johnson & Johnson vaccine
State joins the CDC and FDA in making the call after six women suffer rare blood clots.
(Photo courtesy of Intermountain Healthcare) A nurse gives a jab of the Johnson & Johnson COVID-19 vaccine to a patient at The Orthopedic Surgical Hospital (TOSH) in Murray on Thursday, March 4, 2021 â the first day the new single-shot vaccine was available in Utah. | Updated: 6:53 p.m.
Although there have been no reports of problems with the Johnson & Johnson COVID-19 vaccine in Utah, the state health department is joining federal agencies in recommending that providers âtemporarily pauseâ using it.
Deseret News
Utah, other states ‘pausing’ Johnson & Johnson vaccines after 6 experienced blood clots
None of more than 81,000 Utahns who got the vaccine reported blood clots, state health officials say
Share this story
Medical assistant Tracey Wootton holds several syringes full of the Johnson & Johnson COVID-19 vaccine at a drive-thru vaccination clinic at Intermountain Healthcare’s The Orthopedic Specialty Hospital in Murray on March 4, 2021. Utah announced Tuesday it is pausing administration of the single-dose J&J vaccine while federal health officials investigate reports of “rare, treatable” blood clots experienced by a small number of vaccine recipients.
Spenser Heaps, Deseret News
Utah joined other states Tuesday in pausing the administration of the single-dose Johnson & Johnson COVID-19 vaccine while federal health officials investigate reports of rare but treatable blood clots experienced by a small number of vaccine recipients.
SALT LAKE CITY Utah will temporarily suspend its administration of the Johnson & Johnson COVID-19 vaccine after federal regulators recommended pausing the vaccine to investigate a small number of blood clot issues.
The U.S. Centers for Disease Control and Prevention and Food and Drug Administration said Tuesday that blood clot issues were being investigated in six women who had received the one-dose Johnson & Johnson vaccine several days before reporting the clots.
About 6.8 million doses of the Johnson & Johnson vaccine have been administered in the U.S. so far, according to the CDC, so less than one in a million people have experienced clotting issues with the vaccine.
Utah Dept. of Health temporarily pauses J&J COVID-19 vaccine use following recommendations from FDA, CDC
The Utah Department of Health is asking vaccine providers to temporarily pause the administration of the Johnson & Johnson COVID-19 vaccine over concerns of potential blood clotting.
Posted at 8:51 AM, Apr 13, 2021
and last updated 2021-04-13 14:54:31-04
SALT LAKE CITY â The Utah Department of Health is asking vaccine providers to temporarily pause the administration of the Johnson & Johnson COVID-19 vaccine over concerns of potential blood clotting. The pause is to allow the U.S. Food and Drug Administration (FDA) time to investigate reports of a rare, treatable type of blood clots experienced by a small number of who received the vaccine, a statement from UDOH says.